Given the results of some review studies in postpartum mothers and people with major depressive disorder reveal that there is a negative relationship between the severity of depression and the level of plasma OXT [43–45], it is suggested that OXT plasma levels to be analysed after its intravaginal administration. Here, OXT is linked to depressive symptom measurement.